XML 80 R68.htm IDEA: XBRL DOCUMENT v3.23.1
Note 13 - Stockholders' Equity (Details Textual) - USD ($)
9 Months Ended 12 Months Ended
Dec. 30, 2022
Nov. 29, 2022
Aug. 25, 2022
Jun. 23, 2022
May 19, 2022
May 17, 2022
Jan. 03, 2022
Aug. 17, 2021
Sep. 30, 2022
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2013
Apr. 08, 2021
Dec. 31, 2020
Common Stock, Shares Authorized (in shares)                   100,000,000 100,000,000      
Common Stock, Par or Stated Value Per Share (in dollars per share)           $ 0.001       $ 0.001 $ 0.001   $ 0.001  
Common Stock, Shares, Issued (in shares)                   43,986,079 21,285,706      
Preferred Stock, Shares Authorized (in shares)                   2,500,000 2,500,000      
Preferred Stock, Par or Stated Value Per Share (in dollars per share)                   $ 0.001 $ 0.001      
Preferred Stock, Shares Issued (in shares)                   0 0      
Proceeds from Issuance or Sale of Equity, Total         $ 26,450,000                  
Class of Warrant or Right, Outstanding (in shares)                   35,920,000 1,015,000     515,000
Stock Issued During Period, Value, New Issues                   $ 24,453,528        
Payments of Stock Issuance Costs         $ 1,996,469                  
Stock Issued During Period, Shares, Restricted Stock Award, Net of Forfeitures, Total (in shares) 80,000 9,208 8,333                      
Class of Warrant or Right, Issued by Exchange, Shares (in shares)               500,000   0 500,000      
Shares Issued, Price Per Share (in dollars per share)                   $ 0.50        
Class of Warrant or Right, Issued During Period (in shares)                   34,905,000 0      
Common Stock, Shares, Outstanding, Ending Balance (in shares)                   43,986,079 21,285,706      
Preferred Stock, Shares Outstanding, Ending Balance (in shares)                   0 0      
Restricted Stock Units (RSUs) [Member]                            
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number, Ending Balance (in shares)                 2,408,892 1,387,347 149,636      
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period (in shares)                 2,574,871          
Share-Based Payment Arrangement, Expense                   $ 934,423 $ 481,105      
Share-Based Payment Arrangement, Nonvested Award, Excluding Option, Cost Not yet Recognized, Amount                   $ 639,129        
Restricted Stock Units (RSUs) [Member] | The 2022 Incentive Plan [Member]                            
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number, Ending Balance (in shares)                   1,021,545        
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period (in shares)                   1,021,545        
Prefunded Warrants [Member]                            
Class of Warrant or Right, Outstanding (in shares)           30,425,000                
Class of Warrant or Right, Exercise Price of Warrants or Rights (in dollars per share)               $ 0.001            
Warrant Purchase Agreement [Member]                            
Proceeds from Issuance or Sale of Equity, Total           $ 15,182,075                
Class of Warrant or Right, Exercise Price of Warrants or Rights (in dollars per share)           $ 0.499                
Class of Warrant or Right, Number of Securities Called by Warrants or Rights (in shares)           30,425,000                
Private Placement Warrants [Member]                            
Class of Warrant or Right, Exercise Price of Warrants or Rights (in dollars per share)       $ 0.65                    
Class of Warrant or Right, Number of Securities Called by Warrants or Rights (in shares)       4,250,000                    
Public Offering [Member]                            
Stock Issued During Period, Shares, New Issues (in shares)           15,635,850                
Proceeds from Issuance or Sale of Equity, Total           $ 23,000,000                
Shares Issued, Price Per Share (in dollars per share)           $ 0.50                
Over-Allotment Option [Member]                            
Stock Issued During Period, Shares, New Issues (in shares)         6,900,000                  
Stock Issued During Period, Value, New Issues         $ 3,450,000                  
Private Placement [Member]                            
Proceeds from Issuance of Debt       $ 6,000,000                    
Placement Agent Warrants [Member]                            
Class of Warrant or Right, Issued During Period (in shares)       230,000                    
Director [Member]                            
Stock Issued During Period, Shares, Issued for Services (in shares)             18,641              
Director [Member] | Restricted Stock Units (RSUs) [Member]                            
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period (in shares)                       25,000    
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period (Year)                       3 years    
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Annual Grant                       $ 36,750    
Management [Member]                            
Stock Issued During Period, Shares, Issued for Services (in shares)             48,341              
Management [Member] | Restricted Stock Units (RSUs) [Member]                            
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period (in shares)                 625,000          
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period (Year)                 3 years          
Board of Directors Chairman [Member] | Restricted Stock Units (RSUs) [Member]                            
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Annual Grant                       $ 73,500    
Convertible Preferred Stock [Member]                            
Preferred Stock, Shares Issued (in shares)                   0 0      
Preferred Stock, Shares Outstanding, Ending Balance (in shares)                   0 0